Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.62%1.12B | 10.69%1.02B | 7.02%971.8M | 14.73%3.92B | 15.29%1.05B | 13.31%1.03B | 17.76%924.84M | 11.41%908.02M | 19.18%3.42B | 16.71%911.46M |
| Cost of revenue | 11.22%623.06M | 9.16%571.8M | 7.06%555.19M | 9.06%2.17B | 4.31%556.44M | 9.08%560.23M | 12.84%523.82M | 9.04%518.57M | 17.12%1.99B | 17.92%533.43M |
| Gross profit | 5.52%493.14M | 12.68%451.88M | 6.98%416.61M | 22.59%1.76B | 30.78%494.4M | 18.82%467.36M | 24.87%401.02M | 14.73%389.44M | 22.17%1.43B | 15.05%378.03M |
| Operating expense | 5.27%314.1M | 16.50%292.07M | 6.69%280.56M | 19.96%1.1B | 6.48%283.96M | 35.99%298.39M | 21.36%250.72M | 17.77%262.97M | 20.13%915.99M | 28.55%266.68M |
| Selling and administrative expenses | 5.61%323.15M | 17.35%298.46M | 6.40%284.63M | 14.33%1.12B | 5.35%290.02M | 14.64%305.98M | 20.10%254.34M | 18.21%267.5M | 24.33%980.26M | 24.49%275.29M |
| -General and administrative expense | 5.61%323.15M | 17.35%298.46M | 6.40%284.63M | 14.33%1.12B | 5.35%290.02M | 14.64%305.98M | 20.10%254.34M | 18.21%267.5M | 24.33%980.26M | 24.49%275.29M |
| Other operating expenses | -19.06%739K | 9.79%2M | 13.27%2.3M | 82.47%5.59M | 49.19%831K | 32.32%913K | 72.32%1.82M | 166.36%2.03M | 14.29%3.06M | -54.53%557K |
| Total other operating income | 15.09%9.79M | 54.02%8.38M | -2.91%6.37M | -59.19%27.48M | -24.73%6.89M | -82.35%8.51M | -12.68%5.44M | 74.30%6.56M | 135.42%67.34M | -38.48%9.16M |
| Operating profit | 5.95%179.03M | 6.33%159.81M | 7.57%136.05M | 27.25%656.51M | 89.00%210.44M | -2.83%168.98M | 31.22%150.3M | 8.90%126.47M | 25.97%515.93M | -8.06%111.35M |
| Net non-operating interest income (expenses) | -1.07%-43.32M | -1.15%-43.14M | 5.78%-41.76M | 5.32%-174.92M | -9.35%-44.57M | 16.67%-42.86M | 9.96%-42.65M | 1.90%-44.32M | -1.40%-184.74M | 8.86%-40.76M |
| Non-operating interest income | -9.07%4.71M | -37.42%4M | -19.46%4.69M | 9.71%22.11M | -39.69%4.71M | -3.97%5.18M | 33.34%6.4M | 171.32%5.82M | 65.96%20.15M | 179.77%7.81M |
| Non-operating interest expense | -0.02%48.03M | -3.88%47.15M | -7.37%46.44M | -3.84%197.02M | 1.46%49.29M | -15.46%48.04M | -5.98%49.05M | 5.94%50.14M | 5.43%204.89M | 2.23%48.58M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 19.20%16.22M | 27.19%13.98M | -63.17%3.45M | 5.57%49.36M | 19.81%15.41M | -1.56%13.6M | 12.54%10.99M | -9.23%9.36M | -2.11%46.76M | -8.80%12.86M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 8.74%151.93M | 10.12%130.65M | 6.81%97.74M | 40.49%530.96M | 117.24%181.27M | 2.52%139.72M | 54.19%118.64M | 12.60%91.51M | 37.36%377.94M | -7.78%83.44M |
| Income tax | 6.22%46.24M | 21.91%39.08M | 3.30%32.25M | 120.57%166.19M | 3,553.68%59.13M | 21.47%43.53M | 59.82%32.06M | 47.51%31.22M | 2.92%75.35M | -112.04%-1.71M |
| Net income | 10.19%105.7M | 9.78%91.6M | -31.61%65.49M | 50.60%407.24M | 96.21%132.12M | -3.29%95.92M | 73.04%83.45M | 72.03%95.76M | 48.04%270.41M | 2.03%67.34M |
| Net income continuous operations | 9.88%105.7M | 9.78%91.6M | 8.62%65.49M | 20.54%364.77M | 43.44%122.15M | -4.24%96.19M | 46.70%83.45M | 0.31%60.29M | 49.85%302.6M | 11.65%85.15M |
| Net income discontinuous operations | --0 | 101.18%37K | --0 | 231.96%42.48M | 155.96%9.97M | 78.93%-268K | 63.79%-3.14M | 898.56%35.46M | -66.96%-32.19M | -73.43%-17.82M |
| Noncontrolling interests | 19.07%11.78M | 26.12%9.55M | -65.39%8.43M | 663.45%53.43M | 291.61%11.6M | 33.10%9.9M | 463.10%7.57M | 648.57%24.36M | -55.35%7M | -334.47%-6.05M |
| Net income attributable to the company | 9.17%93.91M | 8.14%82.06M | -20.08%57.06M | 34.32%353.82M | 64.22%120.52M | -6.24%86.03M | 61.86%75.88M | 18.78%71.4M | 57.75%263.41M | 15.73%73.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.17%93.91M | 8.14%82.06M | -20.08%57.06M | 34.32%353.82M | 64.22%120.52M | -6.24%86.03M | 61.86%75.88M | 18.78%71.4M | 57.75%263.41M | 15.73%73.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.14%0.0215 | 8.05%0.0188 | -19.63%0.0131 | 18.22%0.0811 | 29.44%0.0277 | -6.19%0.0197 | 62.62%0.0174 | 38.14%0.0163 | 56.62%0.0686 | 46.58%0.0214 |
| Diluted earnings per share | 9.14%0.0215 | 8.05%0.0188 | -19.63%0.0131 | 18.22%0.0811 | 29.44%0.0277 | -6.19%0.0197 | 62.62%0.0174 | 38.14%0.0163 | 60.28%0.0686 | 49.65%0.0214 |
| Dividend per share | 5.00%0.0105 | -20.00%0.008 | 5.00%0.0105 | 33.87%0.0415 | 9.52%0.0115 | 25.00%0.01 | 53.85%0.01 | 66.67%0.01 | 55.00%0.031 | 5.00%0.0105 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.